Genosco logo

Genosco

Turning unseen possibility into reality through innovative science

26 employees · est. 2008 · Billerica, United States

VS
iktos logo

iktos

Artificial intelligence for new drug design

85 employees · est. 2016 · Paris, France

Genosco is the older company (2008 vs 2016); iktos is the larger of the two.

Side-by-Side Comparison

Genosco iktos
Founded
2008 older 2016
Headquarters
Billerica, United States Paris, France
Employees
26 85 larger
Industry
Biotechnology AI, Biotechnology, Health Care
Funding Stage
Not tracked yet Series A
Total Funding
Not tracked yet $18.90M
Funding Rounds
Not tracked yet 7
Services
Not tracked yet AI-driven drug discovery platform, Generative AI for molecular design, Retrosynthesis and synthesis planning, Automated synthesis and testing, Biological data integration
Target Customers
Not tracked yet Pharmaceutical companies, Biotechnology firms, Academic research institutions, Medicinal and computational chemistry teams
Taxonomy
Biotech, Small-molecule Drugs, Clinical-stage, Precision Medicine, Protein Kinases, Drug Discovery, EGFRm+ Non-small Cell Lung Cancer, Phase 3 Clinical Trial, Janssen Partnership, Medicinal Chemistry, Selective Kinase Inhibitors, Structural Biology, Pharmacology, Interdisciplinary Team, Innovative Science Artificial Intelligence In Drug Discovery, Generative AI For Molecule Design, MedTech SaaS Solutions, Pharmaceutical R&D Productivity, AI-Driven Synthesis Automation, Oncology Drug Development, Auto-Immune Drug Research, Protein-Protein Interaction Targeting, RNA-Protein Interaction Targeting, Chemoinformatics, Machine Learning In Medicinal Chemistry, Robotics In Drug Discovery, Series A Financing, Strategic Pharma Collaborations, Medicinal Chemistry AI
Website
genosco.com iktos.ai
Genosco logo

About Genosco

Genosco is a clinical-stage biotech company founded in 2008, with the slogan "Turning unseen possibility into reality through innovative science." The company focuses on the discovery and development of novel small-molecule drugs for patients with unmet medical needs. Genosco's proprietary G-SMART™...

iktos logo

About iktos

Iktos, founded in 2016 and headquartered in France, stands at the forefront of leveraging Artificial Intelligence for both medicinal chemistry research and novel drug design. Their slogan, "Artificial intelligence for new drug design," encapsulates their mission. The company offers proprietary SaaS...

We will tell you when either one moves

BounceWatch watches Genosco and iktos for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Genosco and iktos — by email.

Frequently Asked Questions

Genosco — Turning unseen possibility into reality through innovative science. iktos — Artificial intelligence for new drug design. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Genosco has raised undisclosed funding while iktos has raised $18.90M.
Genosco and iktos operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Genosco with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genosco on 14 Sep 2024, and iktos on 20 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy